| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 634477 | 49811 | VENOFUSIN BICARBONATO SÓDICO 1 M SOLUCIÓN PARA PERFUSIÓN | VENOFUSIN BICARBONATO SÓDICO 1 M SOLUCIÓN PARA PERFUSIÓN , 10 frascos de 250 ml | 8,4% (1 M) | 6 | 10 | 48 | 10 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/49811/49811_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/49811/49811_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1972-01-01 | 1 | 1 | 1 | 1972-01-01 | 1982-04-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 639948 | 58903 | KABIPAC GLUCOSA 5% SOLUCION PARA PERFUSION | KABIPAC GLUCOSA 5% SOLUCION PARA PERFUSION , 20 frascos de 250 ml | 5% | 6 | 20 | 48 | 20 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58903/58903_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58903/58903_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1990-06-01 | 1 | 1 | 1 | 1990-06-01 | 1990-07-01 | 0 | 2013-10-14 | View Edit Delete | ||||||||||||
| 639963 | 58903 | KABIPAC GLUCOSA 5% SOLUCION PARA PERFUSION | KABIPAC GLUCOSA 5% SOLUCION PARA PERFUSION , 10 frascos de 1.000 ml | 5% | 6 | 10 | 48 | 10 frascos de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58903/58903_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58903/58903_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1990-06-01 | 1 | 1 | 1 | 1990-06-01 | 1990-07-01 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 640458 | 41604 | CLORURO DE SODIO MEIN 0,9% SOLUCION PARA PERFUSION | CLORURO DE SODIO MEIN 0,9% SOLUCION PARA PERFUSION 20 frascos de 50 ml | 0,9% | 6 | 20 | 48 | 20 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41604/41604_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41604/41604_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1965-10-01 | 1 | 1 | 1 | 1965-10-01 | 1990-12-01 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 640466 | 41662 | GLUCOSA 5% MEIN SOLUCION PARA PERFUSION | GLUCOSA 5% MEIN SOLUCION PARA PERFUSION, 20 frascos de 50 ml | 5% | 6 | 20 | 48 | 20 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41662/41662_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41662/41662_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1965-10-01 | 1 | 1 | 1 | 1965-10-01 | 1990-12-01 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 645713 | 32726 | KABIPAC CLORURO DE SODIO 9 MG/ML SOLUCION PARA PERFUSION | KABIPAC CLORURO DE SODIO 9 MG/ML SOLUCION PARA PERFUSION , 20 frascos de 250 ml | 0,9% | 6 | 20 | 48 | 20 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32726/32726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32726/32726_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1959-09-01 | 1 | 1 | 1 | 1959-09-01 | 1995-01-01 | 0 | 2014-04-17 | View Edit Delete | ||||||||||||
| 645721 | 32728 | KABIPAC GLUCOSALINO SOLUCION PARA PERFUSION | KABIPAC GLUCOSALINO SOLUCION PARA PERFUSION, 20 frascos de 250 ml | 3,3% + 0,3% | 6 | 20 | 48 | 20 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32728/32728_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32728/32728_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1959-09-01 | 1 | 1 | 1 | 1959-09-01 | 1995-01-01 | 0 | 2014-04-17 | View Edit Delete | ||||||||||||
| 650823 | 66614 | OXYNORM CONCENTRADO 10 mg/ml, SOLUCION ORAL | OXYNORM CONCENTRADO 10 mg/ml, SOLUCION ORAL , 1 frasco de 30 ml | 10 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66614/66614_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66614/66614_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11860 | MUNDIPHARMA PHARMACEUTICALS S.L. | 2005-02-10 | 1 | 1 | 1 | 2005-02-10 | 2005-02-10 | 1 | 2011-10-26 | Lista I | View Edit Delete | |||||||||||
| 650632 | 66548 | BISOLVON MUCOLITICO 1,6 mg/ ml JARABE | BISOLVON MUCOLITICO 1,6 mg/ ml JARABE, 1 frasco de 200 ml | 1,6 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66548/66548_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66548/66548_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 41334 | OPELLA HEALTHCARE SPAIN S.L. | 2005-01-26 | 1 | 1 | 1 | 2005-01-26 | 2005-01-26 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 650171 | 66349 | LANSOPRAZOL CINFAMED 15 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFAMED 15 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66349/66349_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66349/66349_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2004-09-21 | 1 | 1 | 1 | 2004-09-21 | 2004-09-21 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 650172 | 66350 | LANSOPRAZOL CINFAMED 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFAMED 30 mg CAPSULAS GASTRORRESISTENTES EFG, 14 cápsulas | 30 mg | 6 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66350/66350_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66350/66350_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2004-09-21 | 1 | 1 | 1 | 2004-09-21 | 2004-09-21 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 650173 | 66350 | LANSOPRAZOL CINFAMED 30 mg CAPSULAS GASTRORRESISTENTES EFG | LANSOPRAZOL CINFAMED 30 mg CAPSULAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66350/66350_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66350/66350_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2004-09-21 | 1 | 1 | 1 | 2004-09-21 | 2004-09-21 | 1 | 2012-01-09 | View Edit Delete | ||||||||||||
| 636878 | 57393 | BARIGRAF 555,2 g POLVO PARA SUSPENSION RECTAL | BARIGRAF 555,2 g POLVO PARA SUSPENSION RECTAL , 10 enemas | 555,2 g | 6 | 10 | 14 | 10 enemas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57393/57393_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57393/57393_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 1988-04-01 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 636886 | 57391 | BARIGRAF AD 333,2 g POLVO PARA SUSPENSION ORAL | BARIGRAF AD 333,2 g POLVO PARA SUSPENSION ORAL , 10 envases unidosis de 340 g | 333,2 g | 6 | 10 | 17 | 10 envases unidosis de 340 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57391/57391_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57391/57391_p.pdf | 1 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1988-03-01 | 1 | 1 | 1 | 1988-03-01 | 1988-04-01 | 1 | 2011-02-08 | View Edit Delete | ||||||||||||
| 642918 | 41671 | SUERO FISIOLOGICO VITULIA 0,9% SOLUCION PARA PERFUSION | SUERO FISIOLOGICO VITULIA 0,9% SOLUCION PARA PERFUSION, 20 frascos de 100 ml | 0,9% | 6 | 20 | 48 | 20 frascos de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41671/41671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41671/41671_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1965-10-01 | 1 | 1 | 1 | 1965-10-01 | 1992-09-01 | 0 | 2011-09-09 | View Edit Delete | ||||||||||||
| 645382 | 41671 | SUERO FISIOLOGICO VITULIA 0,9% SOLUCION PARA PERFUSION | SUERO FISIOLOGICO VITULIA 0,9% SOLUCION PARA PERFUSION, 20 frascos de 50 ml | 0,9% | 6 | 20 | 48 | 20 frascos de 50 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41671/41671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41671/41671_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1965-10-01 | 1 | 1 | 1 | 1965-10-01 | 1994-09-01 | 0 | 2011-09-09 | View Edit Delete | ||||||||||||
| 651177 | 65503 | PIREXIN 40 mg/ml SUSPENSION ORAL | PIREXIN 40 mg/ml SUSPENSION ORAL 1 frasco de 150 ml y jeringa oral graduada | 40 mg/ml | 6 | 150 | 26 | 1 frasco de 150 ml y jeringa oral graduada | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/65503/65503_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/65503/65503_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 2003-07-18 | 1 | 1 | 1 | 2003-07-18 | 2005-04-21 | 1 | 2024-10-16 | View Edit Delete | ||||||||||||
| 650120 | 46916 | RESINSODIO POLVO PARA SUSPENSION ORAL | RESINSODIO POLVO PARA SUSPENSION ORAL, 1 frasco de 400 g | 997,5 mg/g | 6 | 400 | 21 | 1 frasco de 400 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/46916/46916_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/46916/46916_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2495 | LABORATORIOS RUBIO S.A. | 1968-11-01 | 1 | 1 | 1 | 1968-11-01 | 2004-10-04 | 0 | 2011-10-27 | 747949 | View Edit Delete | |||||||||||
| 650256 | 66388 | CLARITROMICINA SANDOZ 25 mg/ml GRANULADO PARA SUSPENSION ORAL | CLARITROMICINA SANDOZ 25 mg/ml GRANULADO PARA SUSPENSION ORAL , 1 frasco de 100 ml | 25 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/66388/66388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/66388/66388_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 23615 | SANDOZ FARMACEUTICA S.A. | 2004-09-28 | 1 | 1 | 1 | 2004-09-28 | 2004-09-28 | 1 | 2011-10-28 | View Edit Delete | ||||||||||||
| 650283 | 58355 | HALOPERIDOL ESTEVE 2 mg/ml SOLUCION ORAL | HALOPERIDOL ESTEVE 2 mg/ml SOLUCION ORAL , 1 frasco de 30 ml | 2 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/58355/58355_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/58355/58355_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 1994-11-01 | 1 | 1 | 1 | 1994-11-01 | 1995-05-01 | 1 | 2011-10-17 | View Edit Delete |
Page 61 of 1036, showing 20 records out of 20716 total, starting on record 1201, ending on 1220